<DOC>
	<DOCNO>NCT02393027</DOCNO>
	<brief_summary>Idiopathic Parkinson 's disease ( IPD ) degenerative disease affect dopaminergic system . Clinical symptom IPD commonly begin loss least 40 50 % striatal dopaminergic terminal ( specially putaminal terminal ) . The Dopamine neuronal transporter ( DAT ) highly express protein membrane presynaptic nigrostriatal dopaminergic terminal . The use DAT 's radioligand initial stage disease would lead early detection nigral cell loss . Currently , one DAT 's radioligand obtain market authorization France , 123I-FPCIT , use Single Photon Emission Computed Tomography ( SPECT ) . Otherwise , Positron Emission Tomography ( PET ) , sensitive technology SPECT high resolution become year new gold standard visual analysis quantification neurotransmission system ( include dopaminergic system ) . A DAT tracer label Carbon 11 ( [ 11C ] PE2l ) develop currently use reference various research center . However , order enable clinical use tracer ( currently ca n't short period Carbon 11 ) , unit INSERM U930 `` Imaging Brain '' collaboration CERRP ( Center Studies Research Radiopharmaceuticals ) develop new version tracer , label 18-fluor : [ 18F ] LBT-999 . The main goal study compare [ 18F ] LBT-999 uptake group patient suffer Parkinsonien syndrome group healthy volunteer .</brief_summary>
	<brief_title>Quantification Dopamine Active Transporter ( DAT ) Humans : Validation New Radiophamaceutical , 18F LBT-999</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Dopamine</mesh_term>
	<criteria>Criteria common participant : Age 45 75 year old Signed informed consent Affiliated social security system Criteria patient : idiopathic Parkinson 's disease accord UKPDSBB criterion stage 13 Hoen Yahr ( unilateral disease moderate mild bilateral disease self patient ) Criteria healthy volunteer : match accord age ( Â± 5 year ) Criteria common participant : history take antipsychotic drug dopaminergic effect previous 6 month contraindication MRI person severe claustrophobia patient legal protection measure alcohol drug abuse history ( past 10 year ) history progressive disease affect central nervous system ( blood pressure great equal 180/100 mmHg , chronic lung disease hypoxia , heart failure stage 4 ) medical surgical affection old 3 month history stroke history head trauma ( coma &gt; 24h ) MMS &lt; 24 pregnancy lactate woman without reliable contraception</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>